trending Market Intelligence /marketintelligence/en/news-insights/trending/o78DV0cmvKbL1AZcPJC4zg2 content esgSubNav
In This List

Sonoma Pharmaceuticals CEO, CFO depart; replacement named

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Sonoma Pharmaceuticals CEO, CFO depart; replacement named

Sonoma Pharmaceuticals Inc. announced the departure of President and CEO Jim Schutz and CFO Bob Miller, effective Dec. 12

Schutz also resigned from the board.

The company appointed Frederick Sandford as CEO and interim CFO, effective nine months from Dec. 11, subject to a three-month mutual extension.

Sandford also joined the board as a Class III director, effective Dec. 14. He recently was president and CEO of Command Center Inc.